Àrùn àtọ̀gbẹ jẹ́ àìsàn tó le gan-an tó sì lè pa èèyàn.
Gẹ́gẹ́ bí Àjọ Ìlera Àgbáyé (WHO) ṣe sọ, àrùn àtọ̀gbẹ ló ń fa ikú àwọn èèyàn tó lé ní mílíọ̀nù kan àti ìdajì lọ́dún, ó sì tún jẹ́ ohun tó ń fa àwọn àìsàn mìíràn bíi àrùn ọkàn, àrùn ọpọlọ, àti àìsàn kẹ̀jẹ̀.
Ní ọdún 2019, àrùn àtọ̀gbẹ ni ohun kẹsàn-án tó ń fa ikú kárí ayé, tí wọ́n sì fojú bù ú pé 1.5 mílíọ̀nù èèyàn ló kú nítorí àrùn náà.
Àmọ́ ṣá o, ó ṣeé ṣe kí iye àwọn tó ń kú nítorí àrùn àtọ̀gbẹ pọ̀ ju èyí lọ, nítorí pé kì í fi bẹ́ẹ̀ jẹ́ ohun tó ń fa ikú.
Yàtọ̀ sí àwọn àbájáde tí àrùn àtọ̀gbẹ ń fà ní tààràtà, àrùn náà tún lè yọrí sí onírúurú ìṣòro tó lè halẹ̀ mọ́ ẹ̀mí èèyàn.
Lára àwọn ìṣòro wọ̀nyí ni àìsàn ọkàn, àrùn ẹ̀jẹ̀, àìsàn kíndìnrín, àìsàn ọpọlọ, àti kéèyàn má ríran mọ́.
Àwọn tó ní àrùn àtọ̀gbẹ tún sábà máa ń ní àrùn, wọ́n sì máa ń rọra wo ọgbẹ́, èyí tó lè yọrí sí àwọn ìṣòro tó le gan-an àti ikú pàápàá.
Ó ṣe pàtàkì láti kíyè sí i pé tí wọ́n bá ń bójú tó àrùn àtọ̀gbẹ dáadáa tí wọ́n sì ń tọ́jú rẹ̀, wọ́n lè dín ewu tó wà nínú àrùn náà kù gan-an.
Èyí ní í ṣe pẹ̀lú ṣíṣàkóso èròjà sugar tó wà nínú ẹ̀jẹ̀ dáadáa, ṣíṣe àyẹ̀wò déédéé, àti ṣíṣe àbójútó àwọn nǹkan mìíràn tó ń kó ewu, irú bí ẹ̀jẹ̀ rírẹ àti èròjà cholesterol.
Nípa ṣíṣàkóso àrùn àtọ̀gbẹ lọ́nà tó gbéṣẹ́, àwọn èèyàn lè dín ewu tí wọ́n ní láti ní àwọn ìṣòro kù, kí wọ́n sì mú kí ìlera wọn sunwọ̀n sí i.
Lin YP, Lu TH: Trends in death rate from diabetes according to multiple-cause-of-death differed from that according to underlying-cause-of-death in Taiwan but not in the United States, 1987-2007. J Clin Epidemiol. 2012, 65 (5): 572-6.
Zhu M, Li J, Li Z, Luo W, Dai D, Weaver SR, Stauber C, Luo R, Fu H: Mortality rates and the causes of death related to diabetes mellitus in Shanghai Songjiang District: an 11-year retrospective analysis of death certificates. BMC Endocr Disord. 2015, 15 (): 45.
McFarland KF, Hemaya E: Neonatal mortality in infants of diabetic mothers. Diabetes Care. , 8 (4): 333-6.
Tilghman J: Obesity and diabetes in African American women. ABNF J. , 14 (3): 66-8.
Will JC, Casper M: The contribution of diabetes to early deaths from ischemic heart disease: US gender and racial comparisons. Am J Public Health. 1996, 86 (4): 576-9.
Shigeta Y, Kikkawa R, Kobayashi N, Katabami J: A community study of diabetes in a population with a high diabetes mortality rate. Tohoku J Exp Med. 1983, 141 Suppl (): 257-60.
Danion F, Letscher-Bru V, Guitard J, Sitbon K, Dellière S, Angoulvant A, Desoubeaux G, Botterel F, Bellanger AP, Gargala G, Uhel F, Bougnoux ME, Gerber V, Michel J, Cornu M, Bretagne S, Lanternier F: Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication. Open Forum Infect Dis. 2022, 9 (2): ofab566.
Ìyàsímímọ́: ìtọ́jú ìlera
Oju opo wẹẹbu yii ni a pese fun eto-ẹkọ ati awọn idi alaye nikan ati pe ko ṣe agbekalẹ pese imọran iṣoogun tabi awọn iṣẹ ọjọgbọn.
A ò gbọ́dọ̀ lo ìsọfúnni tó wà nínú ìwé náà láti ṣe àyẹ̀wò tàbí láti wo àìsàn tàbí àìsàn kan wò, àwọn tó bá sì ń wá ìmọ̀ràn nípa ìṣègùn fúnra wọn gbọ́dọ̀ bá dókítà tó ní ìwé àṣẹ sọ̀rọ̀.
Jọwọ ṣe akiyesi nẹtiwọọki neural ti o ṣe agbejade awọn idahun si awọn ibeere, jẹ pataki ti ko tọ nigbati o ba de si akoonu nọmba. Fun apẹẹrẹ, nọmba awọn eniyan ti a ṣe ayẹwo pẹlu aisan kan pato.
Nigbagbogbo wa imọran ti dokita rẹ tabi olupese ilera ti o ni oye miiran nipa ipo iṣoogun kan. Maṣe gbagbe imọran iṣoogun ọjọgbọn tabi idaduro ni wiwa rẹ nitori nkan ti o ti ka lori oju opo wẹẹbu yii. Ti o ba ro pe o le ni pajawiri iṣoogun, pe 911 tabi lọ si yara pajawiri ti o sunmọ julọ lẹsẹkẹsẹ. Ko si ibatan dokita-aisan ti a ṣẹda nipasẹ oju opo wẹẹbu yii tabi lilo rẹ. Bẹni BioMedLib tabi awọn oṣiṣẹ rẹ, tabi ẹnikẹni ti o ṣe alabapin si oju opo wẹẹbu yii, ṣe eyikeyi awọn aṣoju, ṣalaye tabi tumọ, pẹlu ọwọ si alaye ti a pese nibi tabi lilo rẹ.
Ìyàsímímọ́: ẹ̀tọ́ ọmọnìyàn
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) n pese atunṣe fun awọn onihun aṣẹ-aṣẹ ti o gbagbọ pe ohun elo ti o han lori Intanẹẹti ṣe ilokulo awọn ẹtọ wọn labẹ ofin aṣẹ-aṣẹ AMẸRIKA.
Ti o ba gbagbọ ni igbagbọ to dara pe eyikeyi akoonu tabi ohun elo ti o wa ni asopọ pẹlu oju opo wẹẹbu wa tabi awọn iṣẹ ṣe ilokulo aṣẹ-aṣẹ rẹ, iwọ (tabi aṣoju rẹ) le firanṣẹ akiyesi kan si wa ti o beere pe a yọ akoonu tabi ohun elo naa kuro, tabi idilọwọ iraye si rẹ.
A gbọdọ firanṣẹ awọn iwifunni ni kikọ nipasẹ imeeli (wo abala "Ibaṣepọ" fun adirẹsi imeeli).
DMCA nilo pe akiyesi rẹ ti ilokulo aṣẹ-aṣẹ ti a fi ẹsun kan pẹlu alaye wọnyi: (1) apejuwe ti iṣẹ ti o ni aṣẹ-aṣẹ ti o jẹ koko-ọrọ ti ilokulo ti a fi ẹsun kan; (2) apejuwe ti akoonu ti a fi ẹsun kan ati alaye ti o to lati gba wa laaye lati wa akoonu naa; (3) alaye olubasọrọ fun ọ, pẹlu adirẹsi rẹ, nọmba foonu ati adirẹsi imeeli; (4) alaye nipasẹ rẹ pe o ni igbagbọ rere pe akoonu ni ọna ti o ni ẹsun ti ko ni aṣẹ nipasẹ eni aṣẹ-aṣẹ, tabi aṣoju rẹ, tabi nipasẹ iṣẹ ti ofin eyikeyi;
(5) ìpolongo kan láti ọ̀dọ̀ rẹ, tí o fìdí rẹ̀ múlẹ̀ lábẹ́ ìjìyà ẹ̀rí èké, pé ìsọfúnni tó wà nínú ìkéde náà tọ̀nà àti pé o ní àṣẹ láti mú kí àwọn ẹ̀tọ́ ọmọnìyàn tí wọ́n sọ pé wọ́n ti rú ṣẹ ṣẹ;
ati (6) ibuwọlu ti ara tabi itanna ti ẹni ti o ni aṣẹ tabi eniyan ti o ni aṣẹ lati ṣiṣẹ ni orukọ ẹni ti o ni aṣẹ.
Ti o ko ba ṣafikun gbogbo alaye ti o wa loke le ja si idaduro ti ṣiṣe ẹdun rẹ.
Ìfọ̀rọ̀wérọ̀
Jọwọ fi imeeli ranṣẹ si wa pẹlu eyikeyi ibeere / imọran.
How deadly is diabetes?
Diabetes is a serious and potentially deadly disease.
According to the World Health Organization (WHO), diabetes is the direct cause of over 1.5 million deaths per year, and it is a major risk factor for other diseases such as cardiovascular disease, stroke, and kidney failure.
In 2019, diabetes was the ninth leading cause of death globally, with an estimated 1.5 million deaths directly attributed to the disease.
However, the number of deaths attributable to diabetes is likely much higher, as it is often underreported as a cause of death.
In addition to the direct effects of diabetes, the disease can also lead to various complications that can be life-threatening.
These complications include heart disease, stroke, kidney failure, nerve damage, and vision loss.
People with diabetes are also at a higher risk of developing infections and experiencing slower wound healing, which can lead to severe complications and even death.
It is important to note that with proper management and treatment, the risks associated with diabetes can be significantly reduced.
This includes maintaining good blood sugar control, regular check-ups, and managing other risk factors such as high blood pressure and cholesterol levels.
By managing diabetes effectively, individuals can reduce their risk of developing complications and improve their overall health outcomes.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Ní nǹkan bí
BioMedLib nlo awọn kọnputa adaṣe (awọn alugoridimu ẹkọ ẹrọ) lati ṣe agbejade awọn tọkọtaya ibeere ati idahun.
A bẹrẹ pẹlu awọn atẹjade biomedical miliọnu 35 ti PubMed/Medline. Pẹlupẹlu, awọn oju-iwe wẹẹbu ti RefinedWeb.
